in this issue
Regions :: Western Europe
Aptuit Buys Evotec’s Chemical Development Arm
11:03 AM MDT | October 3, 2007 | Alex Scott
Drug development services group Aptuit (Greenwich, CT) says it has acquired the chemical development business of drug discovery firm Evotec (Hamburg) for $64 million in cash. The acquired business comprises activities in process R&D, custom preparation, analytical development, pilot plant manufacturing, and formulation. The business has about 210 staff based at Oxford and Glasgow, U.K., and generated 2006 sales of €26.8 million ($37.2 million). “This acquisition continues Aptuit’s momentum as we assemble a complete suite of drug development...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee